FDA Recalls Another High Blood Pressure Medication Citing Carcinogenic Compound in It

A year ago, FDA recalled many blood pressure medicines over fears that they could lead to cancer. According to FDA, there was a manufacturing defect in those medications. The drugs comprised of active ingredient valsartan. The move triggered a recall from several distributors that could affect countless heart patients. Now, traces of the same impurity are present in some blood pressure drugs. It is another batch of BP medicine probable to have proportions of carcinogen. Prinston Pharmaceutical Inc. recalled one lot of Irbesartan and seven lots of Irbesartan HCTZ tablets. Doctors prescribe those tablets to control high blood pressure and to cure heart failure.

Some of the recalled lots include a combination of medicines. Although there are some medicines that are not a part of the recall, doctors use them as a combination. The release states Irbesartan and amlodipine plus hydrochlorothiazide are used to control high blood pressure. The recalled products comprise of N-nitrosodiethylamine (NDEA) more than adequate daily intake levels. NDEA is a compound mainly present in the smoke of tobacco. According to WHO and the International Agency for Research on Cancer, it can cause cancer. The company has not yet received any news of unfavorable reactions after taking the drugs. According to FDA, NDEA is naturally present in some foods, water, and industrial waste. It is also classified as a probable component to cause cancer in human beings.

The news release said patients who are taking Irbesartan should continue their medication. They should ask for an alternative to the medicine. Prinston, the manufacturer company, says patients should contact their doctor, and take advice for an alternative treatment. Both the medication, Prinston’s Irbesartan and Irbesartan HCTZ were distributed across the country to wholesalers, distributors, and retailers. Formerly, the FDA announced a recall from Major Pharmaceuticals, Solco Healthcare, Mylan Pharmaceuticals, and Teva Pharmaceuticals Industries. The FDA also published a list of medicines with additional information on its website. But FDA asks patients to continue the dose because missing the dose may be dangerous. The FDA states that it may harm if stopped immediately without any alternative treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *